• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病中能量代谢的失调。

Dysregulation of energy metabolism in Alzheimer's disease.

作者信息

Yuan Yue, Zhao Gang, Zhao Yang

机构信息

Department of Neurology, The First Hospital of Jilin University, Changchun, Jilin, 130061, China.

China Resources Pharmaceutical Commercial Group, Beijing, China.

出版信息

J Neurol. 2024 Dec 2;272(1):2. doi: 10.1007/s00415-024-12800-8.

DOI:10.1007/s00415-024-12800-8
PMID:39621206
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11611936/
Abstract

Alzheimer's disease (AD) is one of the most common neurodegenerative diseases. Its etiology and associated mechanisms are still unclear, which largely hinders the development of AD treatment strategies. Many studies have shown that dysregulation of energy metabolism in the brain of AD is closely related to disease development. Dysregulation of brain energy metabolism in AD brain is associated with reduced glucose uptake and utilization, altered insulin signaling pathways, and mitochondrial dysfunction. In this study, we summarized the relevant pathways and mechanisms regarding the dysregulation of energy metabolism in AD. In addition, we highlight the possible role of mitochondrial dysfunction as a central role in the AD process. A deeper understanding of the relationship between energy metabolism dysregulation and AD may provide new insights for understanding learning memory impairment in AD patients and in improving AD prevention and treatment.

摘要

阿尔茨海默病(AD)是最常见的神经退行性疾病之一。其病因及相关机制仍不清楚,这在很大程度上阻碍了AD治疗策略的发展。许多研究表明,AD患者大脑中的能量代谢失调与疾病发展密切相关。AD大脑中的能量代谢失调与葡萄糖摄取和利用减少、胰岛素信号通路改变以及线粒体功能障碍有关。在本研究中,我们总结了AD中能量代谢失调的相关途径和机制。此外,我们强调了线粒体功能障碍在AD进程中可能扮演的核心角色。更深入地了解能量代谢失调与AD之间的关系,可能为理解AD患者的学习记忆障碍以及改善AD的预防和治疗提供新的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b71e/11611936/73ae9c3be8a7/415_2024_12800_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b71e/11611936/73ae9c3be8a7/415_2024_12800_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b71e/11611936/73ae9c3be8a7/415_2024_12800_Fig1_HTML.jpg

相似文献

1
Dysregulation of energy metabolism in Alzheimer's disease.阿尔茨海默病中能量代谢的失调。
J Neurol. 2024 Dec 2;272(1):2. doi: 10.1007/s00415-024-12800-8.
2
Intermittent Hypoxic Conditioning Rescues Cognition and Mitochondrial Bioenergetic Profile in the Triple Transgenic Mouse Model of Alzheimer's Disease.间歇性低氧预处理可挽救阿尔茨海默病三转基因小鼠模型的认知功能和线粒体生物能谱。
Int J Mol Sci. 2021 Jan 5;22(1):461. doi: 10.3390/ijms22010461.
3
Altered glucose metabolism in Alzheimer's disease: Role of mitochondrial dysfunction and oxidative stress.阿尔茨海默病中葡萄糖代谢的改变:线粒体功能障碍和氧化应激的作用。
Free Radic Biol Med. 2022 Nov 20;193(Pt 1):134-157. doi: 10.1016/j.freeradbiomed.2022.09.032. Epub 2022 Oct 4.
4
The Triangle of Death in Alzheimer's Disease Brain: The Aberrant Cross-Talk Among Energy Metabolism, Mammalian Target of Rapamycin Signaling, and Protein Homeostasis Revealed by Redox Proteomics.阿尔茨海默病大脑中的“死亡三角”:氧化还原蛋白质组学揭示能量代谢、雷帕霉素哺乳动物靶点信号传导和蛋白质稳态之间的异常相互作用
Antioxid Redox Signal. 2017 Mar 10;26(8):364-387. doi: 10.1089/ars.2016.6759. Epub 2016 Oct 20.
5
Mitochondrial dysfunction in Alzheimer's disease.阿尔茨海默病中的线粒体功能障碍
Ageing Res Rev. 2025 May;107:102713. doi: 10.1016/j.arr.2025.102713. Epub 2025 Feb 28.
6
Biological sex and DNA repair deficiency drive Alzheimer's disease via systemic metabolic remodeling and brain mitochondrial dysfunction.生物性别和DNA修复缺陷通过全身代谢重塑和脑线粒体功能障碍引发阿尔茨海默病。
Acta Neuropathol. 2020 Jul;140(1):25-47. doi: 10.1007/s00401-020-02152-8. Epub 2020 Apr 24.
7
Energy Crisis Links to Autophagy and Ferroptosis in Alzheimer's Disease: Current Evidence and Future Avenues.能量危机与阿尔茨海默病自噬和铁死亡的关系:当前证据和未来方向。
Curr Neuropharmacol. 2023;21(1):67-86. doi: 10.2174/1570159X20666220817140737.
8
Metabolism: A Novel Shared Link between Diabetes Mellitus and Alzheimer's Disease.代谢:糖尿病与阿尔茨海默病之间的新关联
J Diabetes Res. 2020 Jan 29;2020:4981814. doi: 10.1155/2020/4981814. eCollection 2020.
9
Progress in mitochondrial and omics studies in Alzheimer's disease research: from molecular mechanisms to therapeutic interventions.阿尔茨海默病研究中线粒体和组学研究的进展:从分子机制到治疗干预。
Front Immunol. 2024 Jul 8;15:1418939. doi: 10.3389/fimmu.2024.1418939. eCollection 2024.
10
Cellular and molecular mechanisms underlying perturbed energy metabolism and neuronal degeneration in Alzheimer's and Parkinson's diseases.阿尔茨海默病和帕金森病中能量代谢紊乱与神经元变性的细胞和分子机制。
Ann N Y Acad Sci. 1999;893:154-75. doi: 10.1111/j.1749-6632.1999.tb07824.x.

引用本文的文献

1
Incretin Hormones GLP-1 and GIP Normalize Energy Utilization and Reduce Inflammation in the Brain in Alzheimer's Disease and Parkinson's Disease: From Repurposed GLP-1 Receptor Agonists to Novel Dual GLP-1/GIP Receptor Agonists as Potential Disease-Modifying Therapies.肠促胰岛素激素GLP-1和GIP使阿尔茨海默病和帕金森病患者大脑中的能量利用正常化并减轻炎症:从GLP-1受体激动剂的重新利用到新型GLP-1/GIP双受体激动剂作为潜在的疾病修饰疗法。
CNS Drugs. 2025 Sep 12. doi: 10.1007/s40263-025-01226-z.
2
ROS-dependent localization of glycolytic enzymes to mitochondria.糖酵解酶基于活性氧的线粒体定位
Redox Biol. 2025 Aug 12;86:103812. doi: 10.1016/j.redox.2025.103812.
3

本文引用的文献

1
Glucose 6 phosphate dehydrogenase overexpression rescues the loss of cognition in the double transgenic APP/PS1 mouse model of Alzheimer's disease.葡萄糖-6-磷酸脱氢酶过表达可挽救阿尔茨海默病 APP/PS1 双转基因小鼠模型的认知功能障碍。
Redox Biol. 2024 Sep;75:103242. doi: 10.1016/j.redox.2024.103242. Epub 2024 Jun 17.
2
Brain responses to intermittent fasting and the healthy living diet in older adults.老年人对间歇性禁食和健康生活饮食的大脑反应。
Cell Metab. 2024 Aug 6;36(8):1668-1678.e5. doi: 10.1016/j.cmet.2024.05.017. Epub 2024 Jun 19.
3
Urolithin A improves Alzheimer's disease cognition and restores mitophagy and lysosomal functions.
Central Insulin-Like Growth Factor-1-Induced Anxiolytic and Antidepressant Effects in a Rat Model of Sporadic Alzheimer's Disease Are Associated with the Peripheral Suppression of Inflammation.
中枢胰岛素样生长因子-1在散发性阿尔茨海默病大鼠模型中诱导的抗焦虑和抗抑郁作用与外周炎症抑制有关。
Cells. 2025 Aug 1;14(15):1189. doi: 10.3390/cells14151189.
4
Proteomic signatures of the ε and ε genetic variants and Alzheimer's disease.ε和ε基因变体与阿尔茨海默病的蛋白质组学特征
medRxiv. 2025 Aug 6:2025.08.04.25332945. doi: 10.1101/2025.08.04.25332945.
5
Role of mitochondria in physiological activities, diseases, and therapy.线粒体在生理活动、疾病及治疗中的作用。
Mol Biomed. 2025 Jun 19;6(1):42. doi: 10.1186/s43556-025-00284-5.
6
Exercise orchestrates systemic metabolic and neuroimmune homeostasis via the brain-muscle-liver axis to slow down aging and neurodegeneration: a narrative review.运动通过脑-肌肉-肝脏轴协调全身代谢和神经免疫稳态,以减缓衰老和神经退行性变:一项叙述性综述。
Eur J Med Res. 2025 Jun 12;30(1):475. doi: 10.1186/s40001-025-02751-9.
7
Dysregulated ac4C modification of mRNA in a mouse model of early-stage Alzheimer's disease.早期阿尔茨海默病小鼠模型中mRNA的ac4C修饰失调
Cell Biosci. 2025 Apr 13;15(1):45. doi: 10.1186/s13578-025-01389-8.
尿石素 A 可改善阿尔茨海默病认知,并恢复线粒体自噬和溶酶体功能。
Alzheimers Dement. 2024 Jun;20(6):4212-4233. doi: 10.1002/alz.13847. Epub 2024 May 16.
4
P-tau217 correlates with neurodegeneration in Alzheimer's disease, and targeting p-tau217 with immunotherapy ameliorates murine tauopathy.P-tau217 与阿尔茨海默病中的神经退行性变相关,用免疫疗法靶向 p-tau217 可改善小鼠 tau 病。
Neuron. 2024 May 15;112(10):1676-1693.e12. doi: 10.1016/j.neuron.2024.02.017. Epub 2024 Mar 20.
5
Mitochondrial disorders leading to Alzheimer's disease-perspectives of diagnosis and treatment.导致阿尔茨海默病的线粒体疾病——诊断和治疗的观点。
Geroscience. 2024 Jun;46(3):2977-2988. doi: 10.1007/s11357-024-01118-y. Epub 2024 Mar 8.
6
Microglial Calcium Homeostasis Modulator 2: Novel Anti-neuroinflammation Target for the Treatment of Neurodegenerative Diseases.小胶质细胞钙稳态调节剂2:治疗神经退行性疾病的新型抗神经炎症靶点。
Neurosci Bull. 2024 Apr;40(4):553-556. doi: 10.1007/s12264-023-01153-3. Epub 2023 Nov 23.
7
Alzheimer's disease: From immunotherapy to immunoprevention.阿尔茨海默病:从免疫疗法到免疫预防。
Cell. 2023 Sep 28;186(20):4260-4270. doi: 10.1016/j.cell.2023.08.021. Epub 2023 Sep 19.
8
Role of TET1-mediated epigenetic modulation in Alzheimer's disease.TET1 介导的表观遗传调控在阿尔茨海默病中的作用。
Neurobiol Dis. 2023 Sep;185:106257. doi: 10.1016/j.nbd.2023.106257. Epub 2023 Aug 8.
9
The potential effect of metformin on cognitive and other symptom dimensions in patients with schizophrenia and antipsychotic-induced weight gain: a systematic review, meta-analysis, and meta-regression.二甲双胍对精神分裂症患者认知及其他症状维度和抗精神病药物所致体重增加的潜在影响:一项系统评价、荟萃分析和荟萃回归分析
Front Psychiatry. 2023 Jul 12;14:1215807. doi: 10.3389/fpsyt.2023.1215807. eCollection 2023.
10
CALHM2 V136G polymorphism reduces astrocytic ATP release and is associated with depressive symptoms and Alzheimer's disease risk.CALHM2 V136G 多态性降低星形胶质细胞 ATP 释放,并与抑郁症状和阿尔茨海默病风险相关。
Alzheimers Dement. 2023 Oct;19(10):4407-4420. doi: 10.1002/alz.13366. Epub 2023 Jul 26.